S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging-Reference-Cited by-同舟云学术

S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging

Published:2011-09-22 Issue:2 Volume:90 Page:163-174
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Nipp Martin,Elsner Mareike,Balluff Benjamin,Meding Stephan,Sarioglu Hakan,Ueffing Marius,Rauser Sandra,Unger Kristian,Höfler Heinz,Walch Axel,Zitzelsberger Horst

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-011-0815-6.pdf

Reference56 articles.

1. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167

2. Baudin E, Schlumberger M (2007) New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol 8:148–156

3. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428

4. Shaha AR (2000) Controversies in the management of thyroid nodule. Laryngoscope 110:183–183

5. Chow S-M, Law SCK, Chan JKC, Au S-K, Yau S, Lau W-H (2003) Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated Levels of Interleukin-18 are Associated with Lymph Node Metastasis in Papillary Thyroid Carcinoma;Hormone and Metabolic Research;2024-02-14

2. S100A6: molecular function and biomarker role;Biomarker Research;2023-09-05

3. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential;Biomolecules;2023-07-17

4. S100 proteins in head and neck squamous cell carcinoma (Review);Oncology Letters;2023-07-06

5. S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K/AKT/mTOR pathway;Pathology - Research and Practice;2023-02